Professor | Ma Chiyuan | Asia Growth Partners

Name	Ma Chiyuan
Contact Information	machiyuan75@sina.com
Language ability	English, Chinese
Province	Jiangsu

Name

Ma Chiyuan

Contact Information

machiyuan75@sina.com

Language ability

English, Chinese

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	Doctor of Medicine Selected for Nanjing Military Region 334 High-Level Talent Jiangsu Province 333 Talent Jiangsu Province 'Six Talent Peaks' Jiangsu Province Key Medical Talent
Work Experience	Chief Physician at Eastern Theater General Hospital Professor at Nanjing University Doctoral Supervisor at Nanjing University
Awards	Second Prize for Military Medical Achievements (2008) First Prize for Scientific Progress by the Ministry of Education (2010) Wang Zhongcheng China Neurosurgery Young Physician Award (2015)

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

Doctor of Medicine
Selected for Nanjing Military Region 334 High-Level Talent
Jiangsu Province 333 Talent
Jiangsu Province 'Six Talent Peaks'
Jiangsu Province Key Medical Talent

Work Experience

Chief Physician at Eastern Theater General Hospital
Professor at Nanjing University
Doctoral Supervisor at Nanjing University

Awards

Second Prize for Military Medical Achievements (2008)
First Prize for Scientific Progress by the Ministry of Education (2010)
Wang Zhongcheng China Neurosurgery Young Physician Award (2015)

Areas of Focus	Clinical Medicine (Neurosurgery)
Publications	Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively., Corresponding Author, 2019 MEG3 is associated with gsp oncogene regulation of growth hormone hypersecretion, proliferation and invasiveness of human GH-secreting adenomas., Corresponding Author, 2019 The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas, Corresponding Author, 2018 The Coexistence of Growth Hormone-Producing Pituitary Adenoma and Rathke Cleft Cyst: How Can We Diagnose Preoperation?, Corresponding Author, 2018 Universal Sellar Anatomical Reconstruction Using the Sellar Floor Flap after Endoscopic Pituitary Adenoma Surgery, Corresponding Author, 2018 Serum AGR2 as a useful biomarker for pituitary adenomas, Corresponding Author, 2017 A practical 3D printed simulator for endoscopic endonasal transsphenoidal surgery to improve basic operational skills., Corresponding Author, 2016 Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis., Corresponding Author, 2016 One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas-a technical report, Corresponding Author, 2016 Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness., Corresponding Author, 2015 Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis., Corresponding Author, 2015 The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy, Corresponding Author, 2014

Areas of Focus

Clinical Medicine (Neurosurgery)

Publications

Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively., Corresponding Author, 2019
MEG3 is associated with gsp oncogene regulation of growth hormone hypersecretion, proliferation and invasiveness of human GH-secreting adenomas., Corresponding Author, 2019
The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas, Corresponding Author, 2018
The Coexistence of Growth Hormone-Producing Pituitary Adenoma and Rathke Cleft Cyst: How Can We Diagnose Preoperation?, Corresponding Author, 2018
Universal Sellar Anatomical Reconstruction Using the Sellar Floor Flap after Endoscopic Pituitary Adenoma Surgery, Corresponding Author, 2018
Serum AGR2 as a useful biomarker for pituitary adenomas, Corresponding Author, 2017
A practical 3D printed simulator for endoscopic endonasal transsphenoidal surgery to improve basic operational skills., Corresponding Author, 2016
Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis., Corresponding Author, 2016
One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas-a technical report, Corresponding Author, 2016
Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness., Corresponding Author, 2015
Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis., Corresponding Author, 2015
The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy, Corresponding Author, 2014

Neurosurgery Clinical Medicine Pituitary Adenomas Neuroendoscopy Neuroendocrinology Brain Tumors Dopamine Agonists Neurosurgical Techniques Medical Research Neurosurgical Education

Qianxue Chen - Wuhan University

Daofeng Tian - Wuhan University

Wei Yi - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us